VII^th International Drug Discovery and Development Forum 2022

Professor Nicolas Moitessier

Department of Chemistry, McGill University, DDTP mentor and MI4 Awardee

COVID-19 therapeutics, an academic approach.

Dr. Steven Laplante

Professor, Medicinal Chemistry, Pharmacological Innovation, Scientific co-head of the Nuclear Magnetic Resonance Spectroscopy Laboratory, Centre Armand-Frappier Santé Biotechnologie, Founder of NMX Research and Solutions Inc.

Discovering Drugs and Synergistic Combinations As Potential Therapies For Inhibiting SARS-CoV-2 and Pan-coronavirus Replication

Dr. Matthias Gotte

Former DDTP mentor, Professor and Chair, Department of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, Li Ka Shing Institute of Virology, University of Alberta, Canada

What is new on remdesivir and other covid-19 antiviral treatments

Dr. John W. Gillard

CEO - JNNova Pharma Inc., Adj. Professor, Dept. Pharmacology & Therapeutics, McGill University, Montreal QC

Design and Development of High-Affinity ACE2 Surrogates as Potent Covid19 Therapeutic Agents

Dr. Eric Hoffman

Professor, Pharmaceutical Sciences, Binghamton University State University of New York, CEO AGADA BioSciences, CEO ReveraGen BioPharma

How late should a new drug development program be kept in the academic space? Late-stage exemplars of viltolarsen and vamorolone.

Dr. Suman Rao

Former DDTP trainee, Life Science Venture Capital Associate, LUMIRA Ventures Toronto

Academia-industry session panelist

Professor Jeremy Nicholson

Pro-Vice Chancellor of Health Sciences, Murdoch University, Australia, Emeritus Professor Imperial College, London

Molecular Phenomics Approaches to Understanding the Natural History of COVID-19 and Post-Acute COVID-19 Syndrome

Professor Elaine Holmes

Professor of Computational Medicine & Premier's Fellow & Director of Computational & Systems Medicine, Murdoch University, Perth, Australia

Understanding Microbiome- Metabolic Axis interactions in a healthcare framework

Professor David Goldstein

Director of the Institute for Genomic Medicine, and Professor of Genetics and Development at Columbia University, Co-Founder of Praxis Precision Medicines, CEO of Actio Biosciences

Mendelian genes as rare and common disease targets

Dr. Trevor Pugh

Senior Scientist, Princess Margaret Cancer Centre, Director, Genomics, Ontario Institute for Cancer Research Associate Professor, Department of Medical Biophysics, University of Toronto

Hereditary Cancer Surveillance Using Cell-Free DNA Sequencing

Professor Suhad Ali

Senior Scientist, RI-MUHC, - Cancer Research Program, Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Department of Medicine, Division of Hematology, MUHC

Prolactin Differentiation Therapy in Breast Cancer

Dr. Jianguo (Jeff) Xia

Associate Professor and Chair, Canada Research in Bioinformatics and Big data Analytics, McGill University, Montreal, Canada

Metabolomics: from raw LC-MS spectra to biological insights

Boutayna Rhourri

Associate Professor, Université de Bordeaux/Université de Montréal

Comprehensive Targeted and Non- Targeted Lipidomics Analyses in Failing and Non-Failing heart

Dr. Elizabeth Neumann

Assistant Professor, Department of Chemistry, University of California

Multimodal Mass Spectrometry Imaging Approaches for Probing Complex Biological Systems

Dr. Jean-Jacques Lebrun

Professor of Medicine, McGill University Health Center, Cancer Research Program | Molecular and Translational Oncology

Crisperized Medicine for Precision Oncology

Dr. Katherine Vallis

Professor of Experimental Radiotherapeutics Group Leader, Oxford Institute for Radiation Oncology Honorary Consultant in Clinical Oncology, Oxford University Hospitals, NHS Trust, UK

Antibody-based therapeutics against intracellular cancer targets

Dr. Alain Wagner

Directeur de Recherche, CNRS, Université de Strasbourg, UNISTRA - Laboratoire de conception et application de molécules bioactives

Bioconjugation and more in the field of Antibody Drug Conjugate

Dr. Vincent Mooser

Canada Excellence Research Chair in Genomic Professor, Department of Human Genetics, Faculty of Medicine, McGill University, Montreal Canada

Drugging the human genome - The use of germline genomics in drug discovery and precision drug development

Dr. Anne Marinier

Director of Medicinal Chemistry, Institut de recherche en immunologie et en cancérologie (IRIC), Université de Montréal

Médicament Québec: La Chimiothèque

Dr. Alice Dragomir

Associate Professor at University of Montreal, Faculty of Pharmacy Associate Member, Department of Surgery, Division of Surgical Research, McGill University
Director, Réseau Québécois de Recherche sur les Médicaments (RQRM)

Drug Research : preclinical and post marketing considerations